Oncolytics Biotech, Inc. (ONCY)
0.557
+0.01
(+2.31%)
USD |
NASDAQ |
Oct 09, 16:00
0.55
-0.01
(-1.26%)
Pre-Market: 08:39
Oncolytics Biotech Free Cash Flow (Quarterly) : -8.066M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.066M |
| March 31, 2026 | -7.299M |
| December 31, 2025 | -6.264M |
| September 30, 2025 | -4.900M |
| June 30, 2025 | -4.262M |
| March 31, 2025 | -4.529M |
| December 31, 2024 | -5.199M |
| September 30, 2024 | -3.853M |
| June 30, 2024 | -5.051M |
| March 31, 2024 | -5.545M |
| December 31, 2023 | -4.498M |
| September 30, 2023 | -4.496M |
| June 30, 2023 | -6.303M |
| March 31, 2023 | -5.792M |
| December 31, 2022 | -4.374M |
| September 30, 2022 | -3.258M |
| June 30, 2022 | -5.426M |
| March 31, 2022 | -4.964M |
| December 31, 2021 | -5.085M |
| September 30, 2021 | -3.125M |
| June 30, 2021 | -5.541M |
| March 31, 2021 | -4.398M |
| December 31, 2020 | -4.398M |
| September 30, 2020 | -4.607M |
| June 30, 2020 | -4.520M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.949M |
| December 31, 2019 | -5.497M |
| September 30, 2019 | -3.420M |
| June 30, 2019 | -3.554M |
| March 31, 2019 | -2.549M |
| December 31, 2018 | -3.318M |
| September 30, 2018 | -2.714M |
| June 30, 2018 | 0.4274M |
| March 31, 2018 | -3.678M |
| December 31, 2017 | -2.544M |
| September 30, 2017 | -2.539M |
| June 30, 2017 | -3.443M |
| March 31, 2017 | -2.986M |
| December 31, 2016 | -2.864M |
| September 30, 2016 | -2.321M |
| June 30, 2016 | -2.039M |
| March 31, 2016 | -2.201M |
| December 31, 2015 | -3.275M |
| September 30, 2015 | -2.198M |
| June 30, 2015 | -4.177M |
| March 31, 2015 | -2.223M |
| December 31, 2014 | -2.940M |
| September 30, 2014 | -4.161M |
| June 30, 2014 | -5.301M |
| March 31, 2014 | -5.602M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -181.32M |
| Sangamo Therapeutics, Inc. | -19.30M |
| Sarepta Therapeutics, Inc. | 196.52M |
| Anixa Biosciences, Inc. | -1.77M |
| Mera Pharmaceuticals, Inc. | -- |